Overview

Definition:
-Hyperkalemia is defined as a serum potassium level greater than 5.0-5.5 mEq/L in children, which can be life-threatening due to its effects on cardiac electrophysiology
-In the emergency department, rapid intervention is crucial to prevent arrhythmias and cardiac arrest.
Epidemiology:
-While less common in healthy children, hyperkalemia is a significant concern in pediatric patients with renal insufficiency, certain genetic disorders, burns, or those receiving specific medications
-Premature infants and neonates are at higher risk due to immature renal function.
Clinical Significance:
-Severe hyperkalemia can lead to life-threatening cardiac arrhythmias, including bradycardia, widening QRS complexes, and sine wave patterns on ECG, potentially progressing to ventricular fibrillation and asystole
-Prompt recognition and management are vital for patient survival and preventing neurological sequelae.

Clinical Presentation

Symptoms:
-Often asymptomatic until severe
-Muscle weakness progressing to paralysis
-Palpitations
-Nausea and vomiting
-Shortness of breath
-Confusion.
Signs:
-Cardiac: bradycardia, irregular pulse, hypotension, ECG changes (peaked T waves, flattened P waves, prolonged PR, widened QRS, sine wave)
-Neurologic: lethargy, weakness
-Respiratory: slow, shallow breathing.
Diagnostic Criteria:
-Serum potassium > 5.0-5.5 mEq/L
-ECG changes suggestive of hyperkalemia (e.g., peaked T waves, widened QRS complex) are critical for immediate assessment and guiding therapy, even before laboratory confirmation in a critical patient.

Diagnostic Approach

History Taking:
-Recent illness (e.g., diarrhea, dehydration)
-Known renal disease or dysfunction
-Use of nephrotoxic medications (e.g., ACE inhibitors, ARBs, potassium-sparing diuretics)
-Intake of high-potassium foods or supplements
-Congenital anomalies
-History of rhabdomyolysis or hemolysis.
Physical Examination:
-Assess vital signs (heart rate, blood pressure, respiratory rate)
-Perform a thorough cardiac auscultation for murmurs or arrhythmias
-Evaluate for signs of dehydration or volume overload
-Assess neurologic status for weakness or altered mentation
-Examine for edema or skin changes.
Investigations:
-Serum electrolytes (including potassium, sodium, chloride, bicarbonate, BUN, creatinine)
-ECG is paramount for assessing cardiac risk
-Complete blood count (CBC) to rule out hemolysis
-Urinalysis to assess renal function and identify potential causes
-Arterial or venous blood gas (ABG/VBG) for acid-base status and bicarbonate
-Consider CK levels if rhabdomyolysis is suspected.
Differential Diagnosis:
-Pseudohyperkalemia (hemolysis during blood draw, leukocytosis, thrombocytosis)
-Renal failure
-Hemolysis
-Rhabdomyolysis
-Acidosis
-Adrenal insufficiency
-Medications causing potassium retention
-Tumor lysis syndrome.

Management

Initial Management:
-Stabilization of the cardiac membrane with intravenous calcium is the first-line emergency treatment to counteract the cardiotoxic effects of hyperkalemia
-Simultaneously, initiate measures to shift potassium intracellularly and promote its excretion.
Medical Management:
-1
-Calcium Administration: Calcium gluconate 10% (0.5-1 mL/kg IV over 5-10 minutes) or Calcium chloride 10% (0.2-0.4 mL/kg IV over 5-10 minutes)
-Repeat doses as needed based on ECG changes
-2
-Potassium Shifting Agents: Insulin (0.1 units/kg regular insulin IV bolus followed by 0.1 units/kg/hr infusion) with glucose (0.5-1 g/kg of 50% dextrose IV bolus to prevent hypoglycemia)
-Albuterol (salbutamol) nebulization (2.5-5 mg in saline nebulized over 10-15 minutes)
-Sodium bicarbonate (1-2 mEq/kg IV) if significant acidosis is present
-3
-Potassium Excretion: Loop diuretics (e.g., furosemide 1 mg/kg IV if renal function permits)
-Potassium binders (e.g., sodium polystyrene sulfonate - Kayexalate, 1 g/kg PO/rectally, onset is slow and may cause GI complications).
Surgical Management:
-Renal replacement therapy (dialysis) is the definitive treatment for severe or refractory hyperkalemia, especially in patients with significant renal dysfunction
-This is usually initiated after initial medical stabilization in the ED.
Supportive Care:
-Continuous cardiac monitoring (ECG)
-Frequent reassessment of vital signs and potassium levels
-Fluid management to ensure adequate hydration and renal perfusion
-Correction of acidosis
-Monitoring for hypoglycemia if insulin/dextrose therapy is used
-Strict intake and output monitoring.

Complications

Early Complications:
-Cardiac arrhythmias (bradycardia, heart block, ventricular fibrillation, asystole)
-Cardiac arrest
-Seizures
-Muscle paralysis affecting respiratory muscles.
Late Complications:
-Neurologic deficits if severe hypoxemia occurs due to cardiac arrest
-Electrolyte imbalances during recovery
-Complications related to dialysis if initiated
-Recurrence of hyperkalemia if underlying cause is not addressed.
Prevention Strategies:
-Careful monitoring of potassium levels in at-risk pediatric patients
-Judicious use of medications that can cause hyperkalemia
-Prompt management of conditions leading to hyperkalemia (e.g., renal failure, acidosis)
-Educating caregivers about dietary restrictions for potassium-rich foods if applicable.

Prognosis

Factors Affecting Prognosis:
-Severity of hyperkalemia (serum potassium level)
-Presence and severity of ECG changes
-Speed of diagnosis and initiation of treatment
-Underlying cause of hyperkalemia
-Renal function
-Presence of comorbidities.
Outcomes:
-With prompt and appropriate management, including cardiac stabilization with calcium and intracellular shifting of potassium, the prognosis for acute hyperkalemia is generally good
-Patients can recover fully if cardiac arrest is averted and the underlying cause is treated
-Long-term prognosis depends heavily on the cause and degree of renal involvement.
Follow Up:
-Close monitoring of serum electrolytes and renal function is required
-If hyperkalemia was due to a reversible cause, follow-up aims to ensure resolution
-For chronic conditions leading to hyperkalemia (e.g., renal disease), ongoing management and regular laboratory checks are essential
-Education on dietary management and medication adherence is critical.

Key Points

Exam Focus:
-Always remember the three crucial steps in acute hyperkalemia management: 1
-Membrane stabilization (Calcium)
-2
-Intracellular shift (Insulin/Glucose, Albuterol, Bicarb)
-3
-Potassium excretion (Diuretics, Binders, Dialysis)
-DNB/NEET SS exams often test this sequence and the indications for each agent.
Clinical Pearls:
-In a pediatric emergency, if ECG changes are concerning for hyperkalemia, administer calcium empirically even before serum potassium levels are back, especially if the patient is unstable
-Rapid infusion of insulin/glucose can cause hypoglycemia
-monitor blood glucose closely
-Albuterol is effective but can cause tachycardia and tremors.
Common Mistakes:
-Forgetting to administer calcium first in cases of severe ECG changes
-Administering insulin without adequate glucose replacement leading to dangerous hypoglycemia
-Over-reliance on potassium binders in acute settings due to their slow onset
-Failing to address the underlying cause of hyperkalemia, leading to recurrence.